• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国成年人群中过氧化物酶体增殖物激活受体γ基因多态性及基因-基因相互作用与哮喘风险的关联

Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms and gene-gene interaction with asthma risk in a Chinese adults population.

作者信息

Li Wancheng, Dai Wenjing, Sun Jian, Zhang Wei, Jiang Yi, Ma Chunlan, Wang Chunmao, He Jie

机构信息

Department of Respiratory Medicine, The First Affiliated Hospital of Chengdu Medical College Chengdu 610500, Sichuan, China.

出版信息

Int J Clin Exp Med. 2015 Oct 15;8(10):19346-52. eCollection 2015.

PMID:26770574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4694474/
Abstract

AIMS

To investigate the association between single nucleotide polymorphism (SNP) of peroxisome proliferator-activated receptors γ (PPAR γ) and additional gene-gene interactions on asthma risk.

METHODS

A total of 882 subjects (602 males, 280 females), with a mean age of 61.3±14.8 years old, including 430 asthma patients and 452 normal subjects were selected in this study, including the genotyping of polymorphisms. Logistic regression was performed to investigate association between SNP and asthma. Generalized MDR (GMDR) was used to analysis the interaction among four SNP.

RESULTS

Asthma risk was significantly lower in carriers of Ala allele of the rs1805192 polymorphism than those with Pro/Pro (Pro/Ala+ Ala/Ala versus Pro/Pro, adjusted OR (95% CI)=0.70 (0.51-0.94). In addition, we also found a significant association between rs10865710 and asthma, asthma risk was significantly lower in carriers of G allele of the rs10865710 polymorphism than those with CC (CG+ GG versus CC, adjusted OR (95% CI)=0.68 (0.55-0.95). There was a significant three-locus model (P=0.0107) involving rs1805192, rs10865710 and rs709158, indicating a potential gene-gene interaction among rs1805192, rs10865710 and rs709158. Overall, the three-locus models had a cross-validation consistency of 10 of 10, and had the testing accuracy of 60.72% after covariates adjustment.

CONCLUSIONS

Our results support an important association of rs1805192 and rs10865710 with asthma, and additional interaction among rs1805192, rs10865710 and rs709158.

摘要

目的

研究过氧化物酶体增殖物激活受体γ(PPARγ)单核苷酸多态性(SNP)与其他基因-基因相互作用对哮喘风险的影响。

方法

本研究共选取882名受试者(男性602名,女性280名),平均年龄61.3±14.8岁,其中包括430例哮喘患者和452例正常受试者,并进行多态性基因分型。采用逻辑回归分析SNP与哮喘之间的关联。使用广义多因子降维法(GMDR)分析4个SNP之间的相互作用。

结果

rs1805192多态性位点Ala等位基因携带者的哮喘风险显著低于Pro/Pro基因型者(Pro/Ala + Ala/Ala与Pro/Pro相比,校正比值比(95%可信区间)=0.70(0.51 - 0.94))。此外,我们还发现rs10865710与哮喘之间存在显著关联,rs10865710多态性位点G等位基因携带者的哮喘风险显著低于CC基因型者(CG + GG与CC相比,校正比值比(95%可信区间)=0.68(0.55 - 0.95))。存在一个涉及rs1805192、rs10865710和rs709158的显著三位点模型(P = 0.0107),表明rs1805192、rs10865710和rs709158之间存在潜在的基因-基因相互作用。总体而言,三位点模型的交叉验证一致性为10/10,在调整协变量后测试准确性为60.72%。

结论

我们的研究结果支持rs1805192和rs10865710与哮喘之间存在重要关联,以及rs1805192、rs10865710和rs709158之间存在额外的相互作用。

相似文献

1
Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms and gene-gene interaction with asthma risk in a Chinese adults population.中国成年人群中过氧化物酶体增殖物激活受体γ基因多态性及基因-基因相互作用与哮喘风险的关联
Int J Clin Exp Med. 2015 Oct 15;8(10):19346-52. eCollection 2015.
2
Single-nucleotide polymorphisms of peroxisome proliferator-activated receptor-γ are associated with systemic lupus erythematosus in a Chinese Han population.过氧化物酶体增殖物激活受体γ的单核苷酸多态性与中国汉族人群的系统性红斑狼疮相关。
Clin Exp Dermatol. 2016 Jul;41(5):541-6. doi: 10.1111/ced.12853.
3
Case-control study on peroxisome proliferator-activated receptor gamma polymorphism and interaction with HDL on essential hypertension in Chinese Han.中国汉族人群中过氧化物酶体增殖物激活受体γ基因多态性及其与高密度脂蛋白相互作用对原发性高血压影响的病例对照研究
Iran J Basic Med Sci. 2015 Dec;18(12):1228-32.
4
Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population.中国汉族人群中过氧化物酶体增殖物激活受体γ基因多态性与肥胖对2型糖尿病的相互作用。
Diabetol Metab Syndr. 2017 Jan 19;9:7. doi: 10.1186/s13098-017-0205-5. eCollection 2017.
5
Interaction between peroxisome proliferator-activated receptor gamma and smoking on cardiovascular disease.过氧化物酶体增殖物激活受体γ与吸烟对心血管疾病的相互作用。
Physiol Behav. 2016 Jan 1;153:28-32. doi: 10.1016/j.physbeh.2015.10.014. Epub 2015 Oct 22.
6
Interaction between peroxisome proliferator- activated receptor gamma polymorphism and overweight on diabetic retinopathy in a Chinese case-control study.中国一项病例对照研究中过氧化物酶体增殖物激活受体γ基因多态性与超重对糖尿病视网膜病变的相互作用
Int J Clin Exp Med. 2015 Nov 15;8(11):21647-52. eCollection 2015.
7
Impact of Interaction Between PPAR Alpha and PPAR Gamma on Breast Cancer Risk in the Chinese Han Population.PPARα 与 PPARγ 相互作用对中国汉族人群乳腺癌发病风险的影响。
Clin Breast Cancer. 2017 Aug;17(5):336-340. doi: 10.1016/j.clbc.2016.10.003. Epub 2016 Oct 19.
8
Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han Population.中国汉族人群中PPARG与CYP1A1基因在冠状动脉疾病上的基因-基因相互作用。
Oncotarget. 2017 May 23;8(21):34398-34404. doi: 10.18632/oncotarget.16186.
9
[Association and effects of gene-gene interactions between peroxisome proliferator-activated receptor and pulse pressure].[过氧化物酶体增殖物激活受体与脉压之间基因-基因相互作用的关联及影响]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Oct 10;38(10):1404-1409. doi: 10.3760/cma.j.issn.0254-6450.2017.10.022.
10
[Association of both peroxisome proliferator-activated receptor, gene-gene interactions and the body mass index].[过氧化物酶体增殖物激活受体、基因-基因相互作用与体重指数的关联]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jul;33(7):740-5.

引用本文的文献

1
Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure.过氧化物酶体增殖物激活受体 γ 基因变异体修饰人体气道和全身对室内邻苯二甲酸二丁酯暴露的反应。
Respir Res. 2022 Sep 16;23(1):248. doi: 10.1186/s12931-022-02174-8.
2
Associations Between Gut Microbiota and Asthma Endotypes: A Cross-Sectional Study in South China Based on Patients with Newly Diagnosed Asthma.肠道微生物群与哮喘内型之间的关联:一项基于中国南方新诊断哮喘患者的横断面研究。
J Asthma Allergy. 2021 Aug 12;14:981-992. doi: 10.2147/JAA.S320088. eCollection 2021.
3
PPARγ enhances ILC2 function during allergic airway inflammation via transcription regulation of ST2.过氧化物酶体增殖物激活受体γ通过对ST2的转录调控增强变应性气道炎症期间2型固有淋巴细胞的功能。
Mucosal Immunol. 2021 Mar;14(2):468-478. doi: 10.1038/s41385-020-00339-6. Epub 2020 Aug 18.
4
Enhancer polymorphism rs10865710 associated with traumatic sepsis is a regulator of PPARG gene expression.增强子多态性 rs10865710 与创伤性脓毒症相关,是 PPARG 基因表达的调节剂。
Crit Care. 2019 Dec 30;23(1):430. doi: 10.1186/s13054-019-2707-z.
5
PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.过氧化物酶体增殖物激活受体:气道炎症的关键调节因子及哮喘潜在治疗靶点
Nucl Receptor Res. 2018;5. doi: 10.11131/2018/101306. Epub 2017 Dec 11.
6
PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation.树突状细胞和T细胞中的过氧化物酶体增殖物激活受体γ(PPARγ)在肺部炎症中驱动致病性2型效应反应。
J Exp Med. 2017 Oct 2;214(10):3015-3035. doi: 10.1084/jem.20162069. Epub 2017 Aug 10.

本文引用的文献

1
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.罗格列酮是过氧化物酶体增殖物激活受体-γ激动剂,通过抑制中性粒细胞性哮喘小鼠效应 T 细胞的增殖来减轻气道炎症。
Immunol Lett. 2014 Jan-Feb;157(1-2):9-15. doi: 10.1016/j.imlet.2013.11.004. Epub 2013 Nov 21.
2
Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.熊果酸作为一种潜在的过氧化物酶体增殖物激活受体 γ(PPARγ)激动剂,通过下调变应性哮喘小鼠模型中白细胞介素-5(IL-5)、白细胞介素-13(IL-13)和白细胞介素-17(IL-17)的表达,抑制卵清蛋白(OVA)诱导的气道炎症和气道高反应性(Penh)。
Eur J Pharmacol. 2013 Feb 15;701(1-3):131-43. doi: 10.1016/j.ejphar.2012.11.033. Epub 2012 Nov 28.
3
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.核受体反式转录抑制通路调控巨噬细胞和 T 细胞中的炎症反应。
Nat Rev Immunol. 2010 May;10(5):365-76. doi: 10.1038/nri2748.
4
Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial.过氧化物酶体增殖物激活受体 γ 激动剂治疗在哮喘变应原挑战模型中具有适度作用:一项随机对照试验。
Respir Med. 2010 May;104(5):668-74. doi: 10.1016/j.rmed.2009.11.006. Epub 2009 Nov 26.
5
Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.过氧化物酶体增殖物激活受体γ作为哮喘的新型治疗靶点
J Asthma. 2008 Jan-Feb;45(1):1-8. doi: 10.1080/02770900701247319.
6
A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.一种用于检测基因与基因以及基因与环境相互作用的广义组合方法及其在尼古丁依赖中的应用。
Am J Hum Genet. 2007 Jun;80(6):1125-37. doi: 10.1086/518312. Epub 2007 Apr 25.
7
PPARG locus haplotype variation and exacerbations in asthma.PPARG基因座单倍型变异与哮喘急性加重
Clin Pharmacol Ther. 2007 May;81(5):713-8. doi: 10.1038/sj.clpt.6100119. Epub 2007 Feb 28.
8
Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma.白细胞介素-10参与过氧化物酶体增殖物激活受体γ介导的哮喘抗炎反应。
Mol Pharmacol. 2005 Dec;68(6):1568-75. doi: 10.1124/mol.105.017160. Epub 2005 Sep 8.
9
PPAR-gamma modulates allergic inflammation through up-regulation of PTEN.过氧化物酶体增殖物激活受体γ通过上调磷酸酶和张力蛋白同源物来调节过敏性炎症。
FASEB J. 2005 Jun;19(8):1033-5. doi: 10.1096/fj.04-3309fje. Epub 2005 Mar 23.
10
Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model.过氧化物酶体增殖物激活受体γ在气道中表达,并在小鼠哮喘模型中抑制气道重塑的特征。
J Allergy Clin Immunol. 2004 May;113(5):882-8. doi: 10.1016/j.jaci.2004.02.036.